📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4. (2019)

First Author: McClements L

Attributed to: Confidence in Concept 2012 - Queen's University Belfast funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12885-019-5500-0

PubMed Identifier: 30975104

Publication URI: http://europepmc.org/abstract/MED/30975104

Type: Journal Article/Review

Volume: 19

Parent Publication: BMC cancer

Issue: 1

ISSN: 1471-2407